Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Mitral Valve Disease Market In 2029?

Over the past few years, there has been considerable growth in the size of the mitral valve disease market. It is anticipated to rise from $3 billion in 2024 to $3.3 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the historic period include initiatives to educate patients, satisfactory reimbursement systems and insurance coverage, increased healthcare spending, heightened awareness and screening efforts, and the enlargement of market presence.

What Growth Rate Is Forecasted for the Mitral Valve Disease Market by 2029?

The market for mitral valve disease is anticipated to witness robust expansion in the forthcoming years. It is predicted to escalate to $4.73 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 9.4%. Factors contributing to this growth during the forecasted period include the increasing prevalence of mitral valve disease, a high acceptance rate for minimally invasive procedures, a surge in innovative heart valve surgeries, an increase in venture capital investments, and enhanced manufacturer interest. Key trends predicted for the forecast period encompass technological progression, evolution in transcatheter technologies, and mounting advancements in surgical methodologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp

Which Key Companies Are Shaping the Future of the Mitral Valve Disease Market?

Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

Which Factors Are Driving Demand in the Mitral Valve Disease Industry?

The rise in vascular heart conditions is anticipated to spur the mitral valve disease market’s expansion. These diseases comprise a set of disorders that impact the blood vessels that supply the heart or are located within the heart itself. An intricate combination of lifestyle choices, demographic shifts, medical issues, environmental influences, and genetic factors are contributing to the growing instances of vascular heart conditions. Diseases like ischemic heart disease and hypertension, which fall under the umbrella of vascular heart disorders, can indirectly lead to mitral valve disease by impairing the heart’s structure and function, resulting in conditions that impact the mitral valve. For example, data from the Australian Bureau of Statistics 2020-21 revealed that in June 2024, the National Health Survey by the Australian Institute of Health and Welfare (a government agency in Australia), highlighted an increase in the death rate from cardiovascular disease in males per 100,000 population, surging from 143.7 in 2021 to 148.2 in 2022 in Australia. Consequently, this steady growth in vascular heart conditions propels the mitral valve disease market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16480&type=smp

How Is the Mitral Valve Disease Market Segmented by Several Divisions?

The mitral valve disease market covered in this report is segmented –

1) By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics

2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Mitral Valve Repair: Surgical Repair, Minimally Invasive Repair, Percutaneous Mitral Valve Repair

2) By Mitral Valve Replacement: Mechanical Valve Replacement, Biological Valve Replacement, Transcatheter Mitral Valve Replacement (TMVR)

3) By Cardiac Resynchronization Therapy: Pacemaker Therapy, Implantable Cardioverter-Defibrillators (ICD), Biventricular Pacing

4) By Mitral Valve Therapeutics: Pharmacological Treatments, Anticoagulation Therapy, Mitral Valve Repair Devices

What are the Emerging Market Trends Driving the Growth of the Mitral Valve Disease Industry?

Prominent businesses in the mitral valve disease market are innovating stented tissue valves to cater to the increasing demand for less intrusive therapeutic options. The design of these stented tissue valves ensures sturdy and consistent performance, giving the patients an alternative to conventional surgical measures. For example, Medtronic, an Irish healthcare business, unveiled the Avalus Ultra valve, a sophisticated surgical aortic tissue valve designed for improved convenience during insertion and extended patient care, in April 2024. The new Avalus Ultra, which builds on ten years of clinical experience with the original Avalus valve, boasts a low valve profile for simpler insertion, a PEEK base frame for uniform roundness, and an unparalleled Effective Orifice Area (EOA) that could enhance blood circulation. Moreover, it comes with a radiopaque coil to enable clear visibility for future valve-in-valve procedures.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report

Which Regions Are Driving Growth in the Mitral Valve Disease Market?

Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16480

This Report Delivers Insight On:

1. How big is the mitral valve disease market, and how is it changing globally?

2. Who are the major companies in the mitral valve disease market, and how are they performing?

3. What are the key opportunities and risks in the mitral valve disease market right now?

4. Which products or customer segments are growing the most in the mitral valve disease market?

5. What factors are helping or slowing down the growth of the mitral valve disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model